Search page

A dose ranging study of sting challenge and specific lgE, IgG4, venom skin test and basophil activation responses to ant venom immunotherapy with and without delta-inulin adjuvant

A positive conjunctival allergen challenge is more common in allergic rhinitis patients with conjunctivitis than in local allergic rhinitis individuals with conjunctivitis

A study to assess the impact of allergy on a subject’s sense of smell when exposed to allergen in an Environmental Exposure Chamber (EEC)

A study to assess the impact of nasal congestion on a subject’s perception of facial and head discomfort when exposed to allergen in an Environmental Exposure Chamber (EEC)

AI as a game-changer: predicting biomarkers to transform allergy immunotherapy

Abatacept to induce remission of peanut allergy during oral immunotherapy (ATARI trial): baseline peanut-specific T cell responses of participants

Absence of alpha-tryptase isoforms is associated with less severe adverse events during peanut-oral immunotherapy

Achieving Remission with Peanut Sublingual Immunotherapy

Active immunotherapy with recombinant Bet v 1

Adherence to venom immunotherapy : a french monocentric retrospective study

Adjuvant allergen fusion proteins for the treatment of allergies

Advances in Immunotherapy

Advances in Oral Immunotherapy

Advances in epicutaneous immunotherapy for the management of patients with food allergy

Age and Gender Patterns in Fungal Allergen Sensitization: A Study from Central Ukraine

Age-related fungal molecular clusters revealed by allergen chip assay in Eastern France

Age-related fungal molecular clusters revealed by allergen multiplex in Southern France

Allergen Nomenclature – Allergens newly identified in 2024 through the lens of planetary health

Allergen and Panallergen Sensitization Profile in Pediatric Eosinophilic Esophagitis Patients: a single centre experience

Allergen awareness of patients in allergology consultations at the pneumophthisiology department of the Ignace Deen University Hospital

Allergen characteristics in human milk

Allergen identification in an emerging predatory mite, Cheyletus eruditus. Cross-reactive analysis with other mite allergens

Allergen immunotherapy/Biologicals

Allergen interactions in the innate system vs. the adaptive system

Allergen metabolism by human oral bacteria alters its allergenicity

Allergen protein families: uses and pitfalls

Allergen sensitization as a One Health approach: computational IgE clustering in a large cohort of dogs to resolve exposure profiles across Europe

Allergen specific diagnostic testing

Allergic, but still want them: A Mix Pet Dander Immunotherapy

AllergoOncology: Application of the basophil activation test (BAT) in pre-clinical testing and the first-in-class clinical trial of anti-cancer IgE immunotherapy

AllergoOncology: The role of BAT in pre-clinical and clinical assessments of potential hypersensitivity to anti-cancer IgE immunotherapy

Allergy Therapeutics – Setting a new standard for grass subcutaneous immunotherapy

An interim analysis of a multi-center, oPEn label, Randomized study to investigate the saFEty of an optimal acCelerated scheme for immunoTherapy in adolescent and adult patients with moderate to severe AR with or without asthma in China. (PERFECT)

Analysis of immunological and cellular tolerance biomarkers during bee venom immunotherapy

Anaphylaxis induced by goat’s and sheep’s milk: an allergen that we should keep under surveillance

Anaphylaxis triggered by flower pollen supplement: identification of the allergen involved

Antioxidant pine nut protein hydrolysate as a therapeutic oral immunotherapy agent in a murine model of pine nut allergy

Applying allergen threshold to dietary management of food allergy

Artificial intelligence-based B-cell epitope peptide immunotherapy alleviates chitin-binding protein-induced type 2 airway inflammation in Blomia tropicalis

Assessing specific pro-catabolic mediators (SPMs) as Innovative Biomarkers in Allergen Immunotherapy: Monitoring Treatment Efficacy

Assessing the role of specific IgA in prophylactic sublingual immunotherapy for peanut allergy: A Brown Norway rat study

Assessment of local nasal IgE in patients with suspected dual allergic rhinitis before and after nasal allergen provocation – presentation of 6 cases

Assessment of the Efficacy of Specific Immunotherapy After a Long Break in Asthmatic Patients

Audit of Peanut Allergy Patients Eligible for Oral Immunotherapy (OIT) in a Paediatric Cohort at Galway University Hospital (2020-2023)

B Cell Repertoires and Phenotypes in Food Allergy and Oral Immunotherapy

BDNF as a biomarker for evaluating clinical response in allergic rhinitis patients undergoing allergen-specific immunotherapy

Barley Flour as a Major Allergen in Gluten-Induced Food Allergy

Basophil activation test as a predicting tool for effective Pru p 3 sublingual immunotherapy response in lipid transfer protein allergy

Basophil allergen threshold sensitivity to casein in milk allergic patients

Best candidate for allergen-specific immunotherapy

Biologicals as adds on in oral immunotherapy for IgE mediated food allergy

Birch Rust: Unveiling a Novel Fungal Allergen in Seasonal Airway Allergy Symptoms – Insights from the First Clinical Cohort in Northern Norway

Blocking antibodies from food immunotherapy unravelled at the molecular level

Breast milk allergen specific IgA antibodies and the development of allergic sensitization at 12 months.

Build-Up of Wasp Venom Immunotherapy with Alutard-Depot SQ during Supply Shortage: A Retrospective Case Series

Bumblebee venom allergy as an emerging occupational allergy: safety and efficacy of bumblebee venom immunotherapy in a large single-center cohort

Can symptoms in Alternaria allergy be linked with objective diagnostic criteria? From intranasal allergen challenge to IgE and basophil activation test

Can the Dermatophagoides Pteronyssinus Molecular Allergen Sensitization Profile, assessed with a Skin Prick Test, Be Useful in Evaluating Clinically Relevant House Dust Mite Allergy?

Carry-over effect of 300 IR house dust mite sublingual immunotherapy tablet and relationship with disease activity: a post hoc analysis

Changes in IgG4 and IgE epitope binding profile are greater with sublingual than oral immunotherapy in milk-allergic children, and correspond to efficacy outcomes

Changes in small airway physiology measured by impulse oscillometry in subjects with allergic asthma following methacholine and inhaled allergen challenge

Changing Patterns of Aeroallergen Sensitization in Zagreb: Ragweed as the Predominant Allergen in a Sensitized Adult Population

Characterization of Pana g 1, a novel allergen from Korean ginseng, Panax ginseng triggering Pollen-Food Allergy Syndrome

China’s First Three-Dimensional Indoor Dust Mite Allergen Distribution Map: A Cross-Sectional Study of Dust Mite-Allergic Patients in Guangzhou

Chlorhexidine as a Hidden Everyday Allergen

Chronic Allergen Exposure Induces Accumulation of IgE Plasma Cells in the Lung, Leading to Local IgE Antibody Production

Clinical Assessment of Specific Immunotherapy Efficacy in Individuals with House Dust Mite-Induced Allergic Rhinoconjunctivitis

Clinical Characteristics of Anaphylaxis Secondary to Subcutaneous Allergen-Specific Immunotherapy in a Pediatric Hospital in Mexico

Clinical Evaluation of subcutaneous immunotherapy (SCIT) containing a mixture of mites, in depot polymerized formulation without dilutional effect. Results from a prospective multicenter study

Clinical and immunological comparison between two subcutaneous immunotherapy products in children with allergic rhinitis

Clinical evaluation of an immunotherapy treatment with Vespa velutina venom in allergic patients. Results from a prospective multicenter Study: W-STING Study

Clinical evaluation of the efficacy of profilin isolated from Acanthamoeba as an allergen

Clinical remission of allergic rhinoconjunctivitis with a 300IR 5-grass pollen sublingual immunotherapy tablet

Clonal mast cell disorders, allergy to hymenoptera venom and venom immunotherapy – our experience

Cluster immunotherapy for bee venom in delayed levo-tyrosine formulation with short protocol

Codex Alimentarius & Precautionary Allergen Labelling (PAL): A New Era for Food Safety and Patient Information

Comparing intrinsic sensitizing capacity of cow’s milk allergens β-lactoglobulin and αs-casein with hen’s egg allergen ovalbumin in an in vitro co-culture model using human epithelial and dendritic cells

Comparison of basophil activation by different yellow jacket venoms from three continents and venom used in immunotherapy

Comparison of the efficacy of subcutaneous and sublingual immunotherapy for the treatment of allergic asthma in children

Conjunctival allergen challenge

Controlled exposure to grass and ragweed pollen in an Allergen Exposure Chamber

Correlation between subjective and objective parameters in house dust mite nasal allergen challenge

Cracking the Code: Immunological Changes Leading to Raw Egg Tolerance During Immunotherapy with Cooked Egg

Cross-Sectional Analysis of Allergen Profiles in Marathwada: A Skin Prick Test Study

Cross-tolerance to cashew by prophylactic sublingual immunotherapy with different tree nuts in Brown Norway rats

Cryptomeria as a novel allergen impacts tree pollen sensitization in Ukraine

DBV Technologies – Epicutaneous route: an innovative potential approach to food immunotherapy

Decreased frequency and severity of oral immunotherapy induced gastrointestinal eosinophilic reactions following revisions in treatment protocol

Demystifying the fear of lack of adherence to sublingual immunotherapy (SLIT)

Descriptive Study on the Evolution of Patients Treated with Oral Immunotherapy (OIT) Using Pasteurized Egg White at the Fundación Alcorcón University Hospital

Descriptive study of the evolution of patients after oral immunotherapy with milk at the Hospital Universitario Fundación Alcorcón

Designing Modified Variants of Ara h 1 and Ara h 2 for Safe and Effective Immunotherapy

Development of Eosinophilic Esophagitis in a Child with Multiple Food Allergies: The Role of Omalizumab, Oral Immunotherapy and Dietary Incompliance: A Case Report

Development of monoclonal antibodies against dog allergens and their application for the analysis of dog allergen extracts

Development, characterization and application of aptamers for the detection and quantification of the major peanut allergen Ara h 1

Dietary outcomes following oral immunotherapy for cows milk allergy: Results from the SOCMA Study

Differential study of whole genome expression profiles of peripheral blood mononuclear cells in children with dust mite specific immunotherapy for asthma

Diverse IgE reactivity profiles in patients undergoing allergen immunotherapy, the reflection of regional sensitization – pilot study

Does the Ratio between Allergen and Histamine Wheal Surface-Areas Correlate with the Detection of Specific IgE by a Microarray Platform?

EFFECTIVENESS AND SAFETY OF SPECIFIC SUBLINGUAL IMMUNOTHERAPY WITH Pru p3 EXTRACT IN PATIENTS WITH LTP ALLERGY

Early Immunologic Parameters Predicting Response to Sublingual Immunotherapy in Allergic Rhinitis Patients

Early immunotherapy with aeroallergens and impact on future allergy

Effect of 300 IR house dust mite sublingual immunotherapy tablet in paediatric patients and relationship with disease activity

Effect of sublingual immunotherapy on allergic rhinitis: Real-life data analysis

Effectiveness and Safety Study of Subcutaneous Immunotherapy for Respiratory Allergy to Dermatophagoides and Lepidoglyphus Destructor

Effectiveness and safety of Venom ImmunoTherapy (VIT) with “Rapid Cluster” induction protocol

Effectiveness of sublingual immunotherapy in patients with atopic dermatitis allergic to house dust mite: an open label extension study

Effectivity and serological correlation analysis in patients undergoing their first year of mixed subcutaneous immunotherapy for dust mites and cat

Efficacy Study on Intratonsillar Immunotherapy for Patients with Allergic Rhinitis Induced by House Dust Mites (Tonsil-AIT)

Efficacy and Safety of Hymenoptera Venom Immunotherapy

Efficacy and safety of HDM-specific subcutaneous immunotherapy on atopic dermatitis

Efficacy and safety of sublingual immunotherapy for mite in children and adolescents with AR

Efficacy and safety profile of immunotherapy for multiple allergens in polysensitized patients with allergic rhinitis: a systematic review and meta-analysis

Efficacy of House Dust Mite Immunotherapy in Chinese Allergic Rhinitis Patients with Diverse Sensitization Patterns: A Multicenter Study

Efficacy of virus-like particle (VLP)-based immunotherapy in a mouse model of HDM allergy

Engineering nanostructures for SLIT: a step towards food allergen precision therapy

Epicutaneous Immunotherapy : from mechanism to efficacy

Epicutaneous Immunotherapy with Peanut Allergy

Epitope Analysis and Mutation Design in Jug r 1 for Hypoallergenic Walnut Immunotherapy

European Variations: Unlocking the Differences in Allergen Batteries Across Countries

Evaluation of Sublingual Immunotherapy for Cat Allergy: Results from a Non-Interventional Study

Evaluation of auditory function in children with allergic rhinitis treated with specific immunotherapy

Evaluation of the IgEs amount and basophil activity changes during walnut oral immunotherapy

Evaluation of the efficacy, adverse effects, and cost-effectiveness of sublingual immunotherapy with dominant allergens for allergic rhinitis due to respiratory allergens in adults and children

Evaluation of the tolerability of the administration of subcutaneous immunotherapy in a cluster schedule, in patients with rhinoconjunctivitis and/or asthma with sensitization to Olea europaea with or without sensitization to grasses

Evaluation of total Immunoglobulin D in sublingual immunotherapy for allergic rhinitis

Evidence of kinetic proofreading through allergen specific IgE at the human mast cell IgE receptor

Evolution of pediatric patients with casein-specific IgE values>100 KU/L undergoing cow’s milk oral immunotherapy

Evolving the Allergen Encyclopedia – A Comprehensive and Intuitive Educational Resource

Exacerbation of eosinophilic esophagitis in a child with seasonal allergic rhinitis during sublingual immunotherapy

Expansion of allergen-specific type 2 memory B cells with an altered phenotype after immunotherapy for bee venom or ryegrass pollen allergy

Experience with ALUTARD SQ Immunotherapy in Patients Allergic to Hymenoptera Venom

Exploring Fish Parvalbumins through Allergen Names, Gene Identities, and IgE Reactivities

Exploring the Protective Potential: Subcutaneous Immunotherapy associated with C. acnes as a reductor of COVID-19 Severity in Older Patients – A Single-Center Observational Study

FRIENDLY TREE NUT AND SESAME ORAL IMMUNOTHERAPY PROTOCOTOLS (ALPEDIA-NOITs)

False positives in sIgE to Xip g 1 using a commercial allergen microarray related to polcalcin sensitization

Field Stings in Patients Undergoing Hymenoptera Venom Immunotherapy in a Healthcare Area of Central Spain

First clinical practice of using biologic therapy with dupilumab in combination with allergen-specific immunotherapy in a patient with severe atopic dermatitis and bronchial asthma

Fixed-Dose Oral Immunotherapy for High-Threshold Food Allergy: Efficacy and Safety in Real-World Practice

Flexible and Safe Oral Immunotherapy (OIT) Regimen Using Home Boiled Nut Broths (HBNB)

Food Protein Standards with Defined Allergen Composition for Use as Reference Materials

Food allergen epitopes steering food allergy diagnostics

Food oral immunotherapy monitoring with OITcontrol® is related to reduced number of home adverse reactions and better treatment compliance compared with paper-based monitoring

Food-Dependent Exercise-Induced Anaphylaxis: Prevalence of Wheat as an Allergen Compared to Other Foods

Food-allergen immunotherapy : how do I get started?

From allergen exposure to multi-bioexposome: Lessons from respiratory infections and allergic diseases

Frontiers in Allergen Immunotherapy: evidence from clinical trials

Generation and preclinical characterization of birch pollen allergen Bet v 1 conjugated with a TLR7 activator

Global Stage Session 3 – Successes and challenges of Immunotherapy

Gut Microbial Bile and Amino Acid Metabolism Associate with Peanut Oral Immunotherapy Failure

Harmonizing clinical outcomes in food allergen immunotherapy: COFAITH EAACI Taskforce

High degree of desensitization after one year of early-life peanut oral immunotherapy – SmaChO Randomized Controlled Trial

High degree of sustained unresponsiveness and safety after three years of slow up-dose peanut oral immunotherapy in toddlers – results from the SmaChO study (Small Children Oral Immunotherapy)

High resolution structure of a human IgE mAb epitope on major cat allergen Fel d 1

House dust mite sublingual immunotherapy comprehensively improves asthma and allergic rhinitis in children and adolescents

How Food Allergen Sensitization Influences Asthma in Children with Atopic Dermatitis

Hymenoptera venom immunotherapy with 210 minutes Ultra-Rush protocol: patient profile and potential risk factors for systemic reactions

ILIT.NU: Intralymphatic immunotherapy and placebo affected cSMS similarly in grass pollen allergic individuals in a large clinical trial

Identification of IgE-binding epitopes in the peach allergen R-mandelonitrile lyase

Identification of Thaumatin-like protein (Ole E 13) as a potential allergen in green olives, a case report

Identification of gibberellin-regulated protein as a new allergen in strawberry allergy

Identification of phycocyanin from Galderia sulphuraria as the allergen responsible for allergic reactions in exposed workers

Identification of rBlo t 41 with a Chitin-binding type-2 domain: a Novel Major Allergen from Blomia tropicalis

Identification of the optimal immunotherapy via CAP Inhibition in Vespa velutina anaphylaxis patients

IgE High-Affinity Receptor Expression as a Predictive Biomarker for Oral Immunotherapy Outcomes in Severe Egg and Milk Allergies

IgE reactivity profile to respiratory and food allergen components among patients with allergic rhinitis with and without asthma

IgE-sensitisation profile to peanut allergen components: reassessment of the prevalence and patterns on a global scale

Immune mechanisms of food immunotherapy

Immunologic profile and safety of milk oral immunotherapy in children with severe cow’s milk allergy – a series of cases

Immunophenotypes of Food Allergy and Responses to Immunotherapy Across the Life Course

Immunotherapy for LTP allergy

Immunotherapy for food allergy. What’s new?

Immunotherapy from patient and epidemiological study perspective

Immunotherapy in Food allergies : New frontiers

Immunotherapy in childhoood asthma: is it worth it?

Immunotherapy in food allergy

Immunotherapy in the clinic

Immunotherapy with Vespa velutina nigrithorax venom: safety of ultra-rush protocol and preliminary clinical results

Impact of Age and Allergen Type on Sensitization Changes in Chronic Rhinitis Children

Impact of a 3-tree sublingual immunotherapy liquid formulation in birch family pollen-allergic patients on prevention of disease progression and/or asthma onset

Impact of allergic rhinitis activity on the effect of 300IR house dust mite sublingual immunotherapy tablet in adolescent patients

Impact of different prophylactic sublingual immunotherapy regimes on peanut allergy prevention in Brown Norway rats

Impact of dog ownership on allergen exposure and tolerance development: Analysis of Can f 1 levels in house dust samples

Impact of liquid sublingual immunotherapy on asthma worsening prevention: GINA treatment stepping up results from the real-world EfficAPSI study

Impact of liquid sublingual immunotherapy with mixed pollen allergens on asthma prevention in polyallergic patients: results from the real-world EfficAPSI study

Impact of participant baseline factors on exposure-adjusted incidence of treatment-related adverse events during peanut oral immunotherapy

Impact of reaction conditions on surface modification of glass microtiter wells used in development of allergen microarrays

Impact of sensitization to main allergen molecules during childhood on adult asthma, atopic dermatitis, rhinitis and food allergy in the BAMSE cohort

Increase in airway resistance and respiratory bronchial reactivity is accompanied by cellular and antibody Type 2 immune response in a mouse model of asthma induced by Der p 23 allergen

Increase in maximum tolerated dose and decrease in symptom severity during food challenge in a clinical trial of oral immunotherapy for peanut allergy in children aged 1 to 3 years

Increased Inhibitory Surface Marker PD-1 Expression in CD4+T Cells and Th2+T Cells in Allergen-specific Immunotherapy

Increased the serum Blomia tropicalis antibody levels in children with Dermatophagoides pteronyssinus immunotherapy

Indefinite immunotherapy with different extracts in systemic mastocytosis

Individual Differences in Response to Dust-Mite-Allergen Specific Immunotherapy in Allergic Rhinitis: A Meta-analysis of Randomized Controlled Trials

Inhalant allergen panel- a single center 6-year experience

Innovations in Food Allergy Immunotherapy

Interim safety review of PVX108 peptide immunotherapy in an ongoing Phase 2 trial in peanut-allergic adolescents and children

Intestinal-restricted location of allergen-specific regulatory T cells is driven by oral consumption of the allergen in murine models

Intralymphatic immunotherapy of allergic rhinoconjunctivitis with grass allergoid microcrystalline tyrosine adsorbate produced reduced medication use and symptoms: a double-blind placebo-controlled trial

Intravenous immunotherapy with Der p 1-containing nanoparticles alleviates allergic response in a murine model of allergic rhinitis

Is milk oral immunotherapy using a home up-dosing protocol a viable and safe treatment for the older milk allergic child?

Kinetics of IgG4 after Vespula venom immunotherapy administered with an ultra-rush protocol

Liquid Handling Robotics for Improved Standardization of ELISA Kits for Allergen Detection

Local allergic rhinitis in paediatric patients: prevalence and clinical outcomes in nasal allergen challenge

Long-term Follow-up After Peanut Oral Immunotherapy During Preschool Years: Lessons from the IMPACT Trial

Long-term efficacy and re-sting outcomes following venom immunotherapy discontinuation: A 978-patient analysis

Low dose oral immunotherapy for children with severe cow’s milk allergy

Machine Learning-Based Prediction of Desensitization Success in Oral Immunotherapy for Hen’s Egg Allergy in Children

Management of Eosinophilic Esophagitis as a side effect of food oral immunotherapy

Measurement of serum specific IgE to Ryegrass allergen component Lol p 5 in the TAISAR cohort predicts risk of Thunderstorm Asthma

Methodology of Allergen challenges for airway allergy

Microbiome variation during Dermatophagoides pteronyssinus cultures used in allergen extracts

Minimum resources to run an immunotherapy clinic safely

Missense variant KIT p.D816V suggestive of mast cell disorder predisposes to Hymenoptera venom immunotherapy treatment complications and failure

Modified Peanut Allergen mRNA Induces Cross-Blocking Antibodies that Protect Against Allergic Reactions in an in-vivo Allergy Model

Modified Peanut Allergen mRNA: A Novel Vaccine for Peanut Allergy

Modulation of allergen-specific type 2 memory B cells over the course of 18 months sublingual immunotherapy for house dust mite allergy

Molecular Allergen Sensitization Disparities in a Turkish Population: A Comprehensive Interregional Analysis

Molecular Allergen Sensitization Patterns in Cat, Dog and Horse Allergies in Children

Molecular allergen diagnosis

Molecular allergen sensitizations drive phenotypes of severe asthma in children: evidence from a megacity cohort (SAMP)

Molecular approach to the allergen exposome amongst Mediterranean children

Molecular recognition and cross-reactivity of the major yellow jacket venom allergen Ves v 5 by a highly specific nanobody

Molecular tools in support to walnut oral immunotherapy

Monitoring response to immunotherapy

Monocyte chemotactic factors in the airways of patients with asthma after an allergen challenge

Mucosal delivery of allergen-specific immunotherapy with vaccine adjuvants suppresses allergic disease through both humoral and cellular immune mechanisms

Murine IgG1 corresponding to human IgG4 increased by subcutaneous immunotherapy suppressed activation of group 2 innate lymphoid cells

Murine IgG1 increased by subcutaneous immunotherapy suppressed development of allergic asthma

NOVEL MULTI-NUTS ORAL IMMUNOTHERAPY PROTOCOLS (ALPEDIA-NOITs)

Nanoparticles to improve safety and efficacy of allergen specific immunotherapy: comparison of mesoporous silica nanoparticles and cubosomes

Nasal Allergen Challenges in the clinical setting: Experience of a centre

Nasal allergen challenge

Nationwide pivotal registry study on house dust mite immunotherapy in allergic rhinitis patients with or without asthma in China (NAVIGATOR)

New allergens approved by the WHO/IUIS Allergen Nomenclature Sub-Committee in 2021-2023

New directions in immunotherapy and vaccinology

New mechanisms for the induction of tolerance by Oral Immunotherapy

Nut immunotherapy – Is it ready for prime time?

One-strength dose escalation using a birch pollen allergoid for subcutaneous immunotherapy is safe and well-tolerated in children, adolescents and adults

One-year follow-up of children who achieved sustained unresponsiveness following early oral immunotherapy for various allergens

Open source release of the Allergen Chip national French database of clinical and multiplex IgE data

Oral Immunotherapy

Oral Immunotherapy for Adults with Food Allergies

Oral Immunotherapy for Fish Allergic Children

Oral Immunotherapy with omalizumab in an adult patient with severe milk and egg allergy

Oral immunotherapy (OIT) in walnut and hazelnut co-allergic patients: ELISA inhibition studies to direct treatment approach

Oral immunotherapy in cow’s milk allergic patients

Oral immunotherapy protocols for milk / egg

Oral immunotherapy to hazelnut in children: a single-center retrospective study in an Italian cohort

Outcomes of Bee Re-sting After Cessation of Venom Immunotherapy

Outcomes of low-dose peanut food challenges in preschoolers when initiating peanut oral immunotherapy

Oxidative Balance In Exhaled Breath Condensate In Patients With Allergic Rhinitis: The Effect Of Diet And Allergen Exposure On Oxidative Stress

Passive immunotherapy with anti-Bet v 1 mAb

Patient-reported outcomes after 5 years of oral immunotherapy for peanut allergy: results from the BOPI (Boiled Peanut Oral Immunotherapy) study

Patients undergoing immunotherapy with Alternaria alternata: prevalence of asthma and co-sensitization to other allergens

Patterns of peanut ingestion in remission vs desensitized patients after completion of peanut oral immunotherapy at 3-years post-treatment

Peanut Lectin: Why It Is Not a Major Peanut Allergen

Peanut and tree nut allergen components around the corner – for potential future use in the clinic?

Peanut oral immunotherapy has not recuded basophil activation

Peanut oral immunotherapy in toddlers

Pediatric patients undergoing immunotherapy with alternaria alternata: demographic and clinical characterization

Persisten severe cow’s milk allergy with successful oral immunotherapy in adulthood

Polyclonal desensitization impairs mast cell responses in an allergen specific manner without compromising IgE signaling ability

Positive effect of a 300IR dosing pump-administered liquid sublingual immunotherapy on allergic disease evolution: Results from the observational, prospective, longitudinal PRACTIS study

Positive impact on quality of life with a depigmented-polymerized house dust mite extract immunotherapy

Pre-treating allergic rhinitis sufferers with fexofenadine before allergen exposure

Precautionary Allergen Labelling: International Regulatory Perspective

Predicting clinical response to allergen-specific immunotherapy to D. pteronyssinus using serological pre-treatment parameters

Predicting treatment response to oral immunotherapy in peanut-allergic children using multi-omics risk scores

Predictors of response to oral immunotherapy

Prescription rates and adherence to bee- and vespid- immunotherapy in Austria – a population-based study

Profile of patients treated with the 300IR liquid sublingual immunotherapy for cat allergy and perception of treatment effect: Results from a French survey

Prognostic value of specific IgE ratios in the tolerance of oral immunotherapy with egg allergy

Prostate-Specific Protein Can f 5 as an Allergen in Seminal Fluid Hypersensitivity: A Case Study

Protocols for venom immunotherapy in the era of depot formulations

Randomized Controlled Trial of Sublingual Immunotherapy for Egg Allergy

Randomized controlled trial of pancake oral immunotherapy for egg allergy

Reactions Due to Accidental Peanut Consumption During Epicutaneous Immunotherapy for Peanut Allergy in Toddlers

Real world data on persistence and compliance with sublingual allergen specific immunotherapy, a Dutch experience

Real-World Protective Effects of Epicutaneous Immunotherapy in Peanut-allergic Toddlers

Real-life Non-interventional Post authorization Safety Study with the SQ tree sublingual immunotherapy tablet

Real-life experience of allergen-specific immunotherapy

Real-life experience with long-term oral immunotherapy for nut allergic children: A single center study from Luxembourg

Real-life observational study on the effectiveness of a broad-spectrum allergen product in unresponsive pediatric patients

Real-world study: safety and effectiveness of a subcutaneous glutaraldehyde, polymerized undiluted D.pteronyssinus-D.farinae allergen extract

Real-world study: safety and effectiveness of a subcutaneous glutaraldehyde, polymerized undiluted olive-grasses allergen extract

Recombinantly made allergen panel for the evaluation of nsLTP cross-reactivity profiles in patients

Reduced allergenicity of the mold major allergen Alt a 1 when iron is sufficient: implications in nutritional immunity and immune resilience

Risk Factors for Early Adverse Events of Sublingual Immunotherapy for Allergic Rhinitis and their Impact on Short-term Treatment Outcomes

Role of sublingual immunotherapy in management of patients with moderate to severe allergic rhinitis; one year study

SQ house dust mite (HDM) sublingual immunotherapy (SLIT)-tablet is well-tolerated in children with inadequately controlled HDM allergic asthma

Safety Profile and Clinical Outcome of Sublingual Immunotherapy (SLIT) with Pru p 3 in Patients with LTP Allergy Undergoing Food Reintroduction

Safety and compliance of sublingual immunotherapy with house dust mite extract in patients with atopic dermatitis for 1 year

Safety and efficacy of a 7-week immunotherapy protocol with aluminum hydroxide adsorbed bee venom

Safety and tolerance response of a two day rush protocol treatment in immunotherapy using purified Apis mellifera dry Honeybee venom extract

Safety of Hymenoptera Venom Immunotherapy in Patients with Oncological and Autoimmune Diseases: A Clinical Case Series

Safety of a cluster strategy, effectiveness and immunological changes in allergic children sensitized to house dust mites with native and modified subcutaneous immunotherapy treatment

Safety of oral immunotherapy in preschool aged children with single and multiple food allergy (the ORKA trial): a prospective intervention study

Safety of subcutaneous immunotherapy with mixtures of two allergens at maximum concentration: 10 year real-world data

Safety of ultra-rush immunotherapy starting protocol with the molecular extract Diater Alt a 1 mol mix

Safety profile in clinical trials of sublingual immunotherapy with carbamylated monomeric allergoid

Selecting the right immunotherapy for Vespa velutina nigrithorax anaphylaxis: does one treatment fits all?

Sensitization to common pets’ allergen components in children

Serum Lactate Dehydrogenase levels distinguish atopic dermatitis patients with a predominant production of IL-13, IL-5 and IL-9 in response to house dust mite allergen and increased prevalence of allergic comorbidities

Severe reactions to the food allergen upon skin contact

Short-term benefits of sublingual immunotherapy in routine clinical practice: Patient Benefit Index by class in the observational, prospective, longitudinal study PRACTIS

Short-term benefits of sublingual immunotherapy in routine clinical practice: deciphering factors influencing the patient satisfaction in the observational, prospective, longitudinal study PRACTIS

Slow oral immunotherapy for food allergy – what evidence do we have?

Small Doses, Big Benefits: The Promise of Low-Dose Oral Immunotherapy

Specific IgE and IgG4 changes in adults undergoing peanut immunotherapy combined with omalizumab

Stallergenes Greer – “Allergen Harmony”: New data for a tailored and sustained food and respiratory immunotherapy effect

Starting with Low-Dose Sesame Food Challenges for Oral Immunotherapy

Steroid sparing effect of 300IR house dust mite sublingual immunotherapy tablet in mite allergic rhinitis patients with concomitant asthma

Structural analysis of IgE epitopes of Ara h 2 reveals simultaneous binding of three copies of a human derived IgE Fab fragment to the major peanut allergen

Study design for A multicenter, open label, randomized Study to inveStigate the effIcacy of Subcutaneous immunoTherapy combined with vitamin D3 in children and adolescent patients with allergic rhinitis (ASSIST study)

Study design for compaRison of onset time of therapeutic effects between the one-strength Accelerated dose-escalation and conventional scheme for SCIT with a native HDM allergen Preparation in chIldren and aDolescents with allergic rhinitis (RAPID Study)

Study design for efficacy evaluation of subcutaneOus immunotherApy in patients with obstructive Sleep apnea concomitant with allergIc rhinitiS (OASIS study)

Study of Efficacy of Rush Sub Lingual Immunotherapy (RSLIT) in Cases of Severe Persistent Allergic Rhinitis

Subcutaneous Allergen-specific Immunotherapy in Pediatric Age – a level II hospital experience

Subcutaneous immunotherapy with a depigmented cat allergoid in patients with cat allergy is safe and results primarily in delayed local reactions

Subcutaneous immunotherapy with mannan-conjugated birch pollen allergoids is safe in a pre/co-seasonal treatment regimen – a subgroup comparison

Sublingual immunotherapy for house dust mite allergy induces expansions of allergen-specific memory B cells expressing CD29 and downregulating IL4Rα

Sublingual immunotherapy with Pru p 3 induces DNA methylation changes towards tolerance in dendritic cells from patients with nsLTP allergy

Sublingual immunotherapy with peanut protein extract has an effect in Brown Norway rats sensitised via the skin

Successes and challenges of Immunotherapy

Successes and challenges of Immunotherapy in Poland and EU

Successful immunotherapy with cow’s milk and omalizumab in a 24-year-old patient with extreme cow’s milk allergy

Sympout study: Effectiveness of a sublingual allergen extract in liquid formulation standardized in TBU/ml in patients with bronchial asthma due to house dust mites or pollens

Sympout study: Effectiveness of a sublingual allergen extract in liquid formulation standardized in TBU/ml in pediatric patients with allergic rhinitis due to house dust mites or pollens

Sympout study: Evolution of clinical parameters in a pediatric population allergic to pollens or house dust mites treated with sublingual immunotherapy in liquid formulation standardized in TBU/ml

Sympout study: Need of medication for symptom control in patients with rhinitis and/or bronchial asthma due to house dust mites or pollens in treatment with sublingual immunotherapy in a standardized liquid formulation in TBU/ml

Systemic reactions to subcutaneous immunotherapy in children

Targeting Mast Cells with Briquilimab, an Anti-Human c-Kit (CD117) Antibody, Mitigates COPD-Like Features in an Allergen and Cigarette Smoke-Exacerbated Asthma Model Using Humanized h/mCD117 Mice

Thaumatin-like Protein (TLP) as a Common Allergen in Banana, Kiwi, Grape, and Avocado Allergy: A Case Study

The Distribution of Allergen Sensitization and Screening Panel for Respiratory Allergic Diseases in Seven Geographical Regions of China: A multicenter study

The Efficacy of Sublingual Immunotherapy in Mild versus Moderate Atopic Dermatitis Among Children with House Dust Mite Allergic Rhinitis

The Patient’s perspective on Precautionary Allergen Labelling

The Sting Challenge Test: a key tool for monitoring the effectiveness of venom immunotherapy

The change in quality of life of adults with food allergy treated with oral immunotherapy

The cross-protective activity of allergen immunotherapy-induced blocking antibodies accords with the structural identity of allergens

The definition of the standardization unit of cat allergen extracts and its impact on their potency

The effect of the sphenopalatine ganglion acupuncture on the clinical efficacy of cluster immunotherapy in patients with allergic rhinitis

The efficacy analysis and immunological changes after Alternaria alternata immunotherapy

The epicutaneous immunotherapy for peanut allergy: most recent results and perspectives

The formula of periocular eczema treatment gel prevents skin penetration of allergen extracts Phleum pratense and Dermatophagoides pteronyssinus

The individual benefit of subcutaneous immunotherapy with mannan-conjugated birch pollen allergoids is already evident in the first season immediately after treatment

The overall diet and environmental factors in oral immunotherapy

The safety of an optimal accelerated immunotherapy for allergic rhinitis in adolescent and adult patients in China (PERFECT study)

The successful switch of Hymenoptera venom immunotherapy (VIT) to a different manufacturer

The utility of basophil activation testing in honey bee venom allergy diagnosis and venom immunotherapy

Therapeutic efficacy of a biodegradable microneedle patch loaded with peanut allergen in a peanut allergy model

Timing in oral immunotherapy : Early vs. Late introduction

Timothy Grass Aerosolization in Novel Allergen Exposure Chamber

Title: Parental Concerns and Challenges in Managing Childhood Food Allergies and Their Impact on Health-Related Quality of Life: A Comprehensive Study by the Food Allergen Ingestion Risk (FAIR) Taskforce in the UK and Ireland

Tolerance induction through oral immunotherapy

Towards an artificial intelligence-assisted allergy diagnosis using semantic attributes and allergen multiplex technology

Trained innate immunity and immunotherapy

Treatment satisfaction and health literacy among patients undergoing allergen-specific immunotherapy -Data from a tertiary allergy centre

Tumor Necrosis Factor Receptor 2 (TNFR2) is crucial for the efficacy of Allergen-Specific Immunotherapy in a Pre-clinical Murine Model

Two decades of Allergen Sensitivity: Insights from Prick Test Data in a Chilean Allergic Center

Two-year Outcomes of Low-dose Oral Immunotherapy for Children with Severe Walnut Allergy

Understanding of mechanisms of food immunotherapy

Understanding the Patient: Their Preferences for Venom Immunotherapy

Unmasking Mite Anaphylaxis – a Hidden Oral Allergen

Utility of basophil activation test (BAT) in evaluation of efficacy of venom immunotherapy determined by sting challenge: A systematic review

Utility of conjunctival allergen challenge in the diagnosis of patients with different phenotypes of allergic rhinitis and conjunctival symptoms

Validation of a novel serum-based basophil activation test (iBAT) to evaluate efficacy of a pivotal Phase III PQ Grass immunotherapy trial

Validation of an online pictorial food frequency questionnaire to measure overall maternal diet and food allergen intake

Venom Immunotherapy in children and adolescents: safety and outcome in a study group from a third level Italian center

Venom immunotherapy in children – do we have an age limit ? (case report)

Venom immunotherapy in mastocytosis

Wheat endoglucanase – a novel food allergen

When Immunotherapy Strikes Twice: IgE Hypersensitivity and HES as Dual Adverse Effects of Pembrolizumab

Where are we currently in sublingual immunotherapy for food allergy?

Why So Sensitive? Identifying New Allergic Sensitization in Patients On Subcutaneous Immunotherapy (SCIT)

Аllergen-specific immunotherapy in patients with allergic rhinitis

Сytokine profile in patients with allergic rhinitis during allergen-specific immunotherapy with added vitamin D

Сytokine profiles in patients with allergic rhinitis during allergen-specific immunotherapy with and without added vitamin D

“Picking the Harmony”: The Science Behind Immunotherapy Treatments

“Tuning In”: Patient Profiles Orchestrating Optimized Response to Immunotherapy

Advances in Allergen Immunotherapy

Advances in Allergen Immunotherapy (AIT)

Allergen Immunotherapy

Allergen Immunotherapy Improves Bronchial Epithelial Tolerance and Antiviral Responses in Patients with House Dust Mite Allergic Asthma

Allergen Immunotherapy decreases biologicals use in allergic rhinitis with chronic rhinosinusitis with nasal polyps (CRSwNP)

Allergen Immunotherapy for the prevention of respiratory allergy

Allergen Immunotherapy in the Republic of Kazakhstan

Allergen immunotherapy

Allergen immunotherapy (AIT) in pregnancy, focus on the use of carbamylated monomeric allergoid

Allergen immunotherapy 01

Allergen immunotherapy 02

Allergen immunotherapy 03

Allergen immunotherapy 04

Allergen immunotherapy 05

Allergen immunotherapy 1

Allergen immunotherapy 2

Allergen immunotherapy 3

Allergen immunotherapy 4

Allergen immunotherapy 5

Allergen immunotherapy 6

Allergen immunotherapy 7

Allergen immunotherapy and Anaphylaxis

Allergen immunotherapy and biologicals: when and how

Allergen immunotherapy for airway allergy

Allergen immunotherapy for allergic disease: Indications and contraindications

Allergen immunotherapy in childhood: setting up the therapeutic goals

Allergen immunotherapy in clinical studies

Allergen immunotherapy in food allergy, what’s new?

Allergen immunotherapy in patients with allergic rhinitis and asthma associated with reduced risk of severe COVID-19

Allergen immunotherapy – Basic and clinical perspective

Allergen specific IgE is a stronger predictor of remission following Peanut Oral Immunotherapy in children aged 1-10 years

Allergen-specific IgE-blocking antibodies in the course of allergen immunotherapy

Allergen-specific IgE/IgG4 ratio as biomarker of allergen immunotherapy efficacy in house dust mite-sensitized allergic rhinitis

Allergen-specific immunotherapy based on purified and modified Fel d 1 allergen from cat dander

Alterations in B cell memory induced by house dust mite allergen immunotherapy

Analysis of epinephrine use during peanut (Arachis hypogaea) allergen powder-dnfp oral immunotherapy in individuals with peanut allergy aged 1 to 3 years

Analyzing Factors Influencing Adherence to Classify Adherence Levels in Patients Treated with Allergen Immunotherapy

Application of allergen standardization in allergen-specific immunotherapy (AIT)

Artificial intelligence and precision immunology: pioneering biomarker discovery in allergen immunotherapy

Asthma phenotype markers did not affect allergen immunotherapy effectiveness

Basophil activation test as a marker of desensitization in Very Low-Dose Multi-Nut Immunotherapy and Very Low-Dose Peanut Oral Immunotherapy

Challenges in food allergen immunotherapy

Changing Allergen Immunotherapy Practice Profiles in Mexico

Clinical and immunological aspects in allergen immunotherapy

Clinical outcomes used in allergen immunotherapy in allergic asthma in the era of Data Science

Clinical studies on Allergen Immunotherapy with inhaled allergens: optimization and standardization of methodological approaches

Clinical studies on allergen immunotherapy with inhaled allergens: optimization and standardization of methodological approaches

Consistent long term benefit of allergen immunotherapy in patients with allergic rhinitis

Coordinated specific IgG2 and IgE responses are associated with high clinical benefit of allergen immunotherapy with 300 IR house dust mite sublingual tablets in a large European cohort

Criteria used by health professionals on the selection of allergen immunotherapy in real clinical practice. CHOICE project results from Interim analysis 2023: PATIENT’S RESULTS

Criteria used by health professionals on the selection of allergen immunotherapy in real clinical practice. CHOICE project results from Interim analysis 2023: DOCTOR’S RESULTS

Current knowledge on venom allergen immunotherapy

DRAGO Application: Implementing Adherence and to House Dust Mite Allergen Immunotherapy

Delving deeper in allergen immunotherapy

Development and implementation of an intelligence platform for management of allergen immunotherapy in China

Development of a thermosensitive poloxamer formulation designed to provide a controlled release of the active pharmaceutical ingredient in birch pollen allergen immunotherapy

Discovering new horizons in allergen immunotherapy

Early inflammatory reactions in mice after immunotherapy with an allergen microcrystalline tyrosine adsorbate

Effect of Metformin on allergen specific immunotherapy

Effect of allergen – specific immunotherapy on PFS symptoms

Effect of allergen immunotherapy on quality of life

Effect of allergen specific immunotherapy on PFS symptoms

Effectiveness of House Dust Mite Subcutaneous Immunotherapy on Co-existing Allergen Symptoms in Polysensitized Patients with Allergic Rhinitis: A Multicenter Retrospective Analysis

Effectiveness of allergy immunotherapy on asthma medication use and asthma exacerbations: Results from the Real world Evidence of aLlergy immunotherapY (RELY) study

Effectiveness of allergy immunotherapy on symptom-relieving medication use: Results from the Real world Evidence of aLlergy immunotherapY (RELY) study

Efficacy and safety of allergen immunotherapy in clinical practice

Enhanced Symptom Assessment Accuracy: Allergen Exposure Chambers vs. Nasal Allergen Challenges for Timothy Grass Pollen-Induced Allergic Rhinitis

Epicutaneous Allergen Administration with Microneedles as a Novel Method of Immunotherapy for House Dust Mite (HDM) Allergic Rhinitis

Epicutaneous food allergen immunotherapy

Evaluation of Patients with Venom Immunotherapy Indication When Immunotherapy Preparation Could Not Be Obtained

Exposure-adjusted safety of peanut (Arachis hypogaea) allergen powder-dnfp oral immunotherapy in individuals with peanut allergy aged 1-3 years (POSEIDON trial)

Factors associated with higher serum IgG4 response in children treated with allergen immunotherapy

Flash talks on Allergen Immunotherapy 1

Flash talks on Allergen Immunotherapy 2

Flash talks on Allergen Immunotherapy 3

Flash talks on Allergen Immunotherapy 4

How allergists around the world perceive innovation in the context of allergen Immunotherapy AIT: an international survey

How effective and safe venom allergen immunotherapy is in children

ILIT.NU: Titration of Allergen for Treatment of Grass Pollen Induced Rhinoconjunctivitis with Intralymphatic Immunotherapy

IgG-Epitope Mapping of Birch-Pollen Bet v 1 Allergen in Allergic and Treated Patients for the Design of Hypoallergenic Immunotherapy Allergens

Immunotherapy-induced neutralising antibodies disrupt allergen binding and sustain allergen tolerance in peanut allergy

Immunotherapy-induced neutralizing antibodies disrupt allergen binding and sustain allergen tolerance in peanut allergy

Impact of Security Measures Implementation in Subcutaneous Allergen Immunotherapy Administration at a Pediatric Hospital in Mexico

Incidence of patients who needed to change their allergy immunotherapy product specific to mites or pollens in Spanish allergy unitsIncidence of switching specific allergic immunotherapy products in Spanish allergy units

Intralymphatic immunotherapy with aluminium hydroxide based grass allergen reduced medication use in patients with allergic rhinoconjunctivitis: a double-blind randomized placebo-controlled trial

Long-Term, Real-World Effectiveness of Allergen Immunotherapy in Reducing Infectious Events in Allergic Rhinitis Patients with and without Asthma

Mapping the Patient’s Journey Prior to Allergen Immunotherapy

Microneedles-based transdermal allergen specific immunotherapy protects against gliadin induced anaphylaxis in a mouse model

Modulation of B cell memory responses by house dust mite allergen immunotherapy

New insights on allergen immunotherapy

Novel allergen immunotherapy strategies

Oral immunotherapy decreases expression of pro-inflammatory genes upon re-exposure to allergen in egg allergic children

Ovalbumin-loaded nanoparticles for allergen specific immunotherapy

Patient preference: A multinational discrete-choice-experiment (DCE) in pollen allergen immunotherapy (AIT)

Poloxamer formulation for allergen immunotherapy reduces systemic allergic reactions in a mouse model

Positive outcome of the pivotal Phase III study with PQ Grass, a modified grass allergen subcutaneous immunotherapy (SCIT) product using MicroCrystalline Tyrosine and Monophosphoryl Lipid A as adjuvant system

Predicting the Efficacy of Allergen Immunotherapy in Asthma Based on Initial-Year Outcome: Insights from the Estimated Daily Symptom and Medication Score

Present and future of allergen immunotherapy

Profiling Allergenic Proteins in Allergen Extracts of the Newly Developed Timothy Grass Allergen Specific IgE Assay on a Fully Automated Chemiluminescence Immunoassay Platform – Autolumo® A2000 Plus

Progress in understanding the mechanisms of airborne allergen immunotherapy

Protein and allergen content variability of peanut-containing products used in oral immunotherapy for peanut allergy

Protocol for a randomized, 5-arm study to evaluate the combination of omalizumab and allergen immunotherapy in patients with asthma due to house dust mites

Real-world allergen immunotherapy effectiveness in allergic asthma

Safety Data for House Dust Mite and Pollen Subcutaneous Allergen Immunotherapy in Children: Systemic Reactions and Risk Factors

Safety and Tolerability of Rush Updosing Using a Mugwort Allergoid Extract for Subcutaneous Allergen Immunotherapy

Safety and tolerability of in-season initiation of subcutaneous and sublingual allergen immunotherapy with SQ grass pollen products: a comprehensive review

Should we be concerned when starting allergen immunotherapy in patients with controlled HIV infection or autoimmune diseases?

Study design for the saFety assessment of an Accelerated up-dosing scheme using one Strength of a native house dust mite allergen extract for subcutaneous immunoTherapy in children with allergic asthma in China (FAST II study)

Sublingual allergen immunotherapy in children with AR

Sublingual dust mite allergen immunotherapy reduces respiratory infections in children with allergic rhinitis

Sustained and Long-term effect of allergen immunotherapy in local respiratory allergy

Systematic literature review and adjusted indirect treatment comparisons of 2 allergen immunotherapy treatments for grass pollen–induced allergic rhinitis

Systemic allergic reactions to subcutaneous allergen immunotherapy – A single center experience

TAPAS – a long-term non-interventional study evaluating MCT (MicroCrystalline Tyrosine)-associated allergoids shows non-inferiority of clinical effectiveness in children compared to adults during a 3-year course of allergen immunotherapy

The Quest for Tolerance in Allergen Immunotherapy

The clinical value of allergen detection panel in Guangzhou, southern China: A big data study based on allergen detection in the past 7 years

The journey to registration: challenges for allergen immunotherapy trials

Updates in the clinical management of allergen immunotherapy

Using the AllergyVax app to increase adherence to allergen subcutaneous immunotherapy

Venom Allergen Immunotherapy in Children: Efficacy, Persistence of Efficacy and Impact on Quality of Life

“Rhythm of Success”: Sustaining Benefits in Allergen Immunotherapy

From allergen molecules to allergy management: can molecular diagnosis improve allergen immunotherapy efficacy?

Welcome

Only match titles

What are you looking for?

Knowledge Hub

Website